Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular

Introducción: Los estudios in vitro, que buscan intermediarios de la degradación mitocondrial de ácidos grasos, facilitan el diagnóstico de alteraciones hereditarias o adquiridas en esa ruta metabólica. Objetivo: Analizar la producción de metabolitos en fibroblastos de pacientes con deficiencia de a...

Full description

Autores:
Osorio, José Henry
Tipo de recurso:
Article of journal
Fecha de publicación:
2021
Institución:
Universidad de Caldas
Repositorio:
Repositorio U. de Caldas
Idioma:
spa
OAI Identifier:
oai:repositorio.ucaldas.edu.co:ucaldas/16282
Acceso en línea:
https://doi.org/10.17151/biosa.2015.14.1.5
https://repositorio.ucaldas.edu.co/handle/ucaldas/16282
Palabra clave:
fatty acids
metabolism
mitochondrial β-oxidación
ácidos grasos
metabolismo
β-oxidación mitocondrial
Rights
openAccess
License
Derechos de autor 2015 Biosalud
id UCALDAS2_2fe109db75058e604eeb6b515719a6a0
oai_identifier_str oai:repositorio.ucaldas.edu.co:ucaldas/16282
network_acronym_str UCALDAS2
network_name_str Repositorio U. de Caldas
repository_id_str
dc.title.spa.fl_str_mv Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
dc.title.translated.eng.fl_str_mv In vitro study of very long chain acyl-coa dehydrogenase deficiency with muscular involvement
title Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
spellingShingle Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
fatty acids
metabolism
mitochondrial β-oxidación
ácidos grasos
metabolismo
β-oxidación mitocondrial
title_short Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
title_full Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
title_fullStr Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
title_full_unstemmed Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
title_sort Estudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscular
dc.creator.fl_str_mv Osorio, José Henry
dc.contributor.author.spa.fl_str_mv Osorio, José Henry
dc.subject.eng.fl_str_mv fatty acids
metabolism
mitochondrial β-oxidación
topic fatty acids
metabolism
mitochondrial β-oxidación
ácidos grasos
metabolismo
β-oxidación mitocondrial
dc.subject.spa.fl_str_mv ácidos grasos
metabolismo
β-oxidación mitocondrial
description Introducción: Los estudios in vitro, que buscan intermediarios de la degradación mitocondrial de ácidos grasos, facilitan el diagnóstico de alteraciones hereditarias o adquiridas en esa ruta metabólica. Objetivo: Analizar la producción de metabolitos en fibroblastos de pacientes con deficiencia de acil-CoA deshidrogenasa de cadena muy larga (VLCAD) con afectación muscular, incubados con ácido oleico deuterado. Materiales y Métodos: Se incubaron fibroblastos de tres pacientes con deficiencia de acil-CoA deshidrogenasa de cadena muy larga (VLCAD) con cardiomiopatía y de 10 controles en presencia de ácido oleico deuterado. Resultados: Se encontró un perfil característico luego de la incubación de fibroblastos con esta deficiencia. Conclusión: Este sustrato podría ser usado para realizar diagnóstico in vitro de la deficiencia de VLCAD con afectación muscular.
publishDate 2021
dc.date.accessioned.none.fl_str_mv 2021-02-23 16:03:24
2021-03-07T10:01:28Z
dc.date.available.none.fl_str_mv 2021-02-23 16:03:24
2021-03-07T10:01:28Z
dc.date.issued.none.fl_str_mv 2021-02-23
dc.type.spa.fl_str_mv Artículo de revista
Sección Artículos Originales
dc.type.eng.fl_str_mv Journal Article
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1657-9550
dc.identifier.uri.none.fl_str_mv https://doi.org/10.17151/biosa.2015.14.1.5
https://repositorio.ucaldas.edu.co/handle/ucaldas/16282
dc.identifier.doi.none.fl_str_mv 10.17151/biosa.2015.14.1.5
dc.identifier.eissn.none.fl_str_mv 2462-960X
identifier_str_mv 1657-9550
10.17151/biosa.2015.14.1.5
2462-960X
url https://doi.org/10.17151/biosa.2015.14.1.5
https://repositorio.ucaldas.edu.co/handle/ucaldas/16282
dc.language.iso.spa.fl_str_mv spa
language spa
dc.relation.citationendpage.none.fl_str_mv 50
dc.relation.citationissue.spa.fl_str_mv 1
dc.relation.citationstartpage.none.fl_str_mv 44
dc.relation.citationvolume.spa.fl_str_mv 14
dc.relation.ispartofjournal.spa.fl_str_mv Biosalud
dc.relation.references.spa.fl_str_mv Merritt JL 2nd, Vedal S, Abdenur JE, Au SM, Barshop BA, Feuchtbaum L, et al. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening. Mol Genet Metab 2014; 111(4):484-92.
Kler RS, Jackson S, Bartlett K, Bindoff LA, Eaton S, Pourfarzam M, et al. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem 1991; 266:22932-38.
Nada MA, Chace DH, Sprecher H, Roe CR. Investigation of ß-oxidation intermediates in normal and MCAD deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med 1995; 54:59- 66.
Ventura FV, Costa CG, Struys EA, Ruiter J, Allers P, Ijlst L, et al. Quantitative acylcarnitine profile in fibroblasts using U-13Cpalmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 1999; 281:1-17.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
Osorio JH. Producción de metabolitos en fibroblastos incubados con ácido oleico deuterado. Archiv Med (Manizales) 2013; 13(2):202-207.
Aoyama T, Ueno I, Hashimoto T. Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gen product, is a rate-limiting enzyme in long-chain fatty acid β-oxidation system. The cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem 1994; 269:19088-94.
Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, et al. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem. Biophys Res Commun 1993; 191:1369-72.
Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long chain acyl-coenzyme A dehydrogenase. J Biol Chem 1992; 267:1027-33.
Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, et al. Purification of human verylong-chainacyl- coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 1995; 95:2465-73.
Andresen BS, Bross P, Vianey-Saban C, Divry P, Zabot MT, Roe CR, et al. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Molec Genet 1996; 5:461-72.
Aoyama T, Souri M, Ueno I, Kamijo T, YamagushI S, Rhead WJ, et al. Cloning of human very-longchain acylcoenzyme A dehydrogenase and molecular characterization of its deficiency in two patients. Am J Hum Gen 1995; 57:273-83.
Vianey-Saban C, Divry P, Brivet M, Nada M, Zabot MT, Mathieu M, et al. Mitochondrial very-long-chain acylcoenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta 1998; 269:43-62.
Olgivie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM. Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 1994; 44:467-73.
Minetti C, Garavaglia B, Bado M, Invernizzi F, Bruno C, Rimoldi M, et al. Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria. Neuromuscul Disord 1998; 8:3- 6.
Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 2010; 33(5):469-77.
Moczulski D, Majak I, Mamczur D. An overview of beta-oxidation disorders. Postepy Hig Med Dosw (Online) 2009; 63:266-77.
Kompare M, Rizzo WB. Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol 2008; 15(3):140-9.
Osorio JH, Pourfarzam M. Early diagnosis of neurometabolic diseases by tandem mass spectrometry. Acylcarnitine profile from cord blood. Rev. Neurol. 2004; 38(1):11-16.
Kølvraa s, Gregersen N, Christiensen E, Hobolth N. In vitro fibroblasts studies in a patient with C6- C10 dicarboxilic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982; 126:53-67.
Manning NJ, Olpin SE, Pollit RJ, Webley JA. Comparison of 9.10-3HPalmitic and 9.10-3Hmyristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inher Metab. Dis 1990; 13:58-68.
Olpin SE, Manning NJ, Carpenter K, Middleton B, Pollit RJ. Differential diagnosis of hydroxydicarboxylic aciduria based on release of 3H2O from [9,10-3H]-myristic and [9,10-3H]-palmitic acids by intact cultured fibroblasts. J Inher Metab Dis 1992; 15:883-890.
Osorio JH, Lluch M, Ribes A. Analysis of organic acids after incubation with (16-2H3)palmitic acid in fibroblasts from patients with mitochondrial beta-oxidation defects. J Inherit Metab Dis. 2003; 26(8):795-803.
dc.relation.citationedition.spa.fl_str_mv Núm. 1 , Año 2015 : Enero - Junio
dc.relation.bitstream.none.fl_str_mv https://revistasojs.ucaldas.edu.co/index.php/biosalud/article/download/3803/3513
https://revistasojs.ucaldas.edu.co/index.php/biosalud/article/download/3803/3514
dc.rights.spa.fl_str_mv Derechos de autor 2015 Biosalud
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Derechos de autor 2015 Biosalud
https://creativecommons.org/licenses/by/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf

dc.publisher.spa.fl_str_mv Universidad de Caldas
dc.source.spa.fl_str_mv https://revistasojs.ucaldas.edu.co/index.php/biosalud/article/view/3803
institution Universidad de Caldas
bitstream.url.fl_str_mv https://repositorio.ucaldas.edu.co/bitstream/ucaldas/16282/1/ORE.xml
bitstream.checksum.fl_str_mv 831b4e9e8945d6597cdf8b9f0329d581
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositorio Digital de la Universidad de Caldas
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1800543110737952768
spelling Osorio, José Henry43b46d33b293a5dc46681ff0a7e157a42021-02-23 16:03:242021-03-07T10:01:28Z2021-02-23 16:03:242021-03-07T10:01:28Z2021-02-231657-9550https://doi.org/10.17151/biosa.2015.14.1.5https://repositorio.ucaldas.edu.co/handle/ucaldas/1628210.17151/biosa.2015.14.1.52462-960XIntroducción: Los estudios in vitro, que buscan intermediarios de la degradación mitocondrial de ácidos grasos, facilitan el diagnóstico de alteraciones hereditarias o adquiridas en esa ruta metabólica. Objetivo: Analizar la producción de metabolitos en fibroblastos de pacientes con deficiencia de acil-CoA deshidrogenasa de cadena muy larga (VLCAD) con afectación muscular, incubados con ácido oleico deuterado. Materiales y Métodos: Se incubaron fibroblastos de tres pacientes con deficiencia de acil-CoA deshidrogenasa de cadena muy larga (VLCAD) con cardiomiopatía y de 10 controles en presencia de ácido oleico deuterado. Resultados: Se encontró un perfil característico luego de la incubación de fibroblastos con esta deficiencia. Conclusión: Este sustrato podría ser usado para realizar diagnóstico in vitro de la deficiencia de VLCAD con afectación muscular.Introduction: In vitro studies for searching intermediates of mitochondrial fatty acid degradation, are a tool for diagnosis of hereditary or adquire alterations of the above mentioned metabolic pathway. Objective: To analize the metabolite production in fibroblasts from patientes with very long chain acylCoA deficiency and muscular involvement incubated with deuterated oleic acid. Materials and Methods: Fibroblasts of three patients with very long chain acyl-CoA deficiency and cardiomyopathy and ten control were incubated with deuterated oleic acid. Results: It was found a characteristic profile after incubation of fibroblats with this deficiency. Conclusion: This substrate could be used to perform in vitro diagnosis of VLCAD deficiency with musclar involvement.application/pdfspaUniversidad de CaldasDerechos de autor 2015 Biosaludhttps://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://revistasojs.ucaldas.edu.co/index.php/biosalud/article/view/3803fatty acidsmetabolismmitochondrial β-oxidaciónácidos grasosmetabolismoβ-oxidación mitocondrialEstudio In vitro de la deficiencia de Acil-CoA deshidrogenasa de cadena muy larga con afectación muscularIn vitro study of very long chain acyl-coa dehydrogenase deficiency with muscular involvementArtículo de revistaSección Artículos OriginalesJournal Articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a855014414BiosaludMerritt JL 2nd, Vedal S, Abdenur JE, Au SM, Barshop BA, Feuchtbaum L, et al. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening. Mol Genet Metab 2014; 111(4):484-92.Kler RS, Jackson S, Bartlett K, Bindoff LA, Eaton S, Pourfarzam M, et al. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem 1991; 266:22932-38.Nada MA, Chace DH, Sprecher H, Roe CR. Investigation of ß-oxidation intermediates in normal and MCAD deficient human fibroblasts using tandem mass spectrometry. Biochem Mol Med 1995; 54:59- 66.Ventura FV, Costa CG, Struys EA, Ruiter J, Allers P, Ijlst L, et al. Quantitative acylcarnitine profile in fibroblasts using U-13Cpalmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta 1999; 281:1-17.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.Osorio JH. Producción de metabolitos en fibroblastos incubados con ácido oleico deuterado. Archiv Med (Manizales) 2013; 13(2):202-207.Aoyama T, Ueno I, Hashimoto T. Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gen product, is a rate-limiting enzyme in long-chain fatty acid β-oxidation system. The cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem 1994; 269:19088-94.Aoyama T, Uchida Y, Kelley RI, Marble M, Hofman K, Tonsgard JH, et al. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem. Biophys Res Commun 1993; 191:1369-72.Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Novel fatty acid β-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long chain acyl-coenzyme A dehydrogenase. J Biol Chem 1992; 267:1027-33.Aoyama T, Souri M, Ushikubo S, Kamijo T, Yamaguchi S, Kelley RI, et al. Purification of human verylong-chainacyl- coenzyme A dehydrogenase and characterization of its deficiency in seven patients. J Clin Invest 1995; 95:2465-73.Andresen BS, Bross P, Vianey-Saban C, Divry P, Zabot MT, Roe CR, et al. Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Molec Genet 1996; 5:461-72.Aoyama T, Souri M, Ueno I, Kamijo T, YamagushI S, Rhead WJ, et al. Cloning of human very-longchain acylcoenzyme A dehydrogenase and molecular characterization of its deficiency in two patients. Am J Hum Gen 1995; 57:273-83.Vianey-Saban C, Divry P, Brivet M, Nada M, Zabot MT, Mathieu M, et al. Mitochondrial very-long-chain acylcoenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta 1998; 269:43-62.Olgivie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM. Very long-chain acyl coenzyme A dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 1994; 44:467-73.Minetti C, Garavaglia B, Bado M, Invernizzi F, Bruno C, Rimoldi M, et al. Very-long-chain acyl-coenzyme A dehydrogenase deficiency in a child with recurrent myoglobinuria. Neuromuscul Disord 1998; 8:3- 6.Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 2010; 33(5):469-77.Moczulski D, Majak I, Mamczur D. An overview of beta-oxidation disorders. Postepy Hig Med Dosw (Online) 2009; 63:266-77.Kompare M, Rizzo WB. Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol 2008; 15(3):140-9.Osorio JH, Pourfarzam M. Early diagnosis of neurometabolic diseases by tandem mass spectrometry. Acylcarnitine profile from cord blood. Rev. Neurol. 2004; 38(1):11-16.Kølvraa s, Gregersen N, Christiensen E, Hobolth N. In vitro fibroblasts studies in a patient with C6- C10 dicarboxilic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982; 126:53-67.Manning NJ, Olpin SE, Pollit RJ, Webley JA. Comparison of 9.10-3HPalmitic and 9.10-3Hmyristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inher Metab. Dis 1990; 13:58-68.Olpin SE, Manning NJ, Carpenter K, Middleton B, Pollit RJ. Differential diagnosis of hydroxydicarboxylic aciduria based on release of 3H2O from [9,10-3H]-myristic and [9,10-3H]-palmitic acids by intact cultured fibroblasts. J Inher Metab Dis 1992; 15:883-890.Osorio JH, Lluch M, Ribes A. Analysis of organic acids after incubation with (16-2H3)palmitic acid in fibroblasts from patients with mitochondrial beta-oxidation defects. J Inherit Metab Dis. 2003; 26(8):795-803.Núm. 1 , Año 2015 : Enero - Juniohttps://revistasojs.ucaldas.edu.co/index.php/biosalud/article/download/3803/3513https://revistasojs.ucaldas.edu.co/index.php/biosalud/article/download/3803/3514OREORE.xmltext/xml2636https://repositorio.ucaldas.edu.co/bitstream/ucaldas/16282/1/ORE.xml831b4e9e8945d6597cdf8b9f0329d581MD51ucaldas/16282oai:repositorio.ucaldas.edu.co:ucaldas/162822021-03-07 10:01:28.707Repositorio Digital de la Universidad de Caldasbdigital@metabiblioteca.com